about
Bile acids in treatment of ocular diseasePreventing a Mass Disease: The Case of Gallstones Disease: Role and Competence for Family PhysiciansBear bile: dilemma of traditional medicinal use and animal protectionReview article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases.Ursodeoxycholic acid treatment of vanishing bile duct syndromes.Restoration of the unfolded protein response in pancreatic β cells protects mice against type 1 diabetes.Apoptosis in diseases of the liver.Primary sclerosing cholangitis: updates in diagnosis and therapyEffect of ursodeoxycholic Acid alone and ursodeoxycholic Acid plus domperidone on radiolucent gallstones and gallbladder contractility in humansUrsodeoxycholic acid and endothelial-dependent, nitric oxide-independent vasodilatation of forearm resistance arteries in patients with coronary heart disease.From immunobiology to β-cell biology: the changing perspective on type 1 diabetesParenteral nutrition-associated liver disease in adult and pediatric patients.Intrahepatic cholestasis of pregnancy-current achievements and unsolved problemsTherapeutic Equivalence of Ursodeoxycholic Acid Tablets and Ursodeoxycholic Acid Capsules for the Treatment of Primary Biliary Cirrhosis.Bile acids in the assessment of hepatocellular function.Phosphoinositide 3-kinase-dependent Ras activation by tauroursodesoxycholate in rat liver.Ursodeoxycholic acid treatment in isolated chronic graft-vs.-host disease of the liver.Costs and effectiveness of extracorporeal gallbladder stone shock wave lithotripsy versus laparoscopic cholecystectomy. A randomized clinical trial. McGill Gallstone Treatment Group.Laparoscopic cholecystectomy in adult cystic fibrosis.Prospective case-cohort study of intestinal colonization with enterococci that produce extracellular superoxide and the risk for colorectal adenomas or cancerPharmacokinetic analysis of 14C-ursodiol in newborn infants using accelerator mass spectrometry
P2860
Q24653326-10C5F615-A34A-48BB-A357-A9FBDBCD7079Q26741095-1B8FC525-D2B3-4E42-93F0-29C70D1BC5DEQ27498916-D53CABD0-EF9C-4100-81F9-ABB2461CE9A3Q33723536-2A30168C-7564-484C-A492-2FB1C2AAD31AQ33866782-C2195A34-0314-406A-8DE2-26DD606641A1Q34213205-6B1A62BC-3A84-4F1F-B90F-A80E06A29295Q34248399-15A9D9D9-D5A6-43DA-9592-7FDAF47E3666Q34382536-37A3665B-D0D8-4756-AEEF-24536981D390Q35960449-3F7FA088-7A50-422C-981D-8FBB17E6B636Q36053433-915ED9C0-2984-4B38-AB9B-89488C63E452Q36124036-D7429C15-21FF-4BF3-B5A9-A2D8852A6D97Q36506091-51349EA2-5629-4FDD-8631-3C5A96AFF208Q37294587-E922AF28-7D5E-4500-A8A6-EB9546BF30CDQ39816216-41A0FA86-5EF9-4F5A-A818-53C03E39C946Q41137497-05E5DCEC-EDF1-48AA-93EF-18144E3FAEE5Q42259932-486954EF-0ECB-45AC-8D3B-2E10B3FC8268Q46824252-127693E7-FA45-4A74-B02D-8E6985A13655Q50152844-5B26BE16-EFFD-43D6-B188-6D8D8EC5948FQ50157415-557E52B9-C5BB-4C55-BA12-47B88369D045Q56883414-5FBC1A7A-75E5-4C4B-81C9-83A370AF4B47Q57150351-CCE081FE-2B2E-4149-B0D4-DB556DF91E66
P2860
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Ursodiol for hepatobiliary disorders.
@en
type
label
Ursodiol for hepatobiliary disorders.
@en
prefLabel
Ursodiol for hepatobiliary disorders.
@en
P2093
P1476
Ursodiol for hepatobiliary disorders.
@en
P2093
Khandelwal M
Kowalski TE
P304
P356
10.7326/0003-4819-121-3-199408010-00009
P407
P577
1994-08-01T00:00:00Z